NDC11 00169790301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00169-7903-01 | 00169-7903 |
| 00169-7903-1 | 00169-7903 |
| 0169-7903-01 | 0169-7903 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REBINYN | COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED | Novo Nordisk | 0ea37235-35fd-410d-b8c4-40ba15fe1294 | 2022-08-11 | Warnings, Adverse reactions | 0169-7903-01 0169-7903 00169790301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.